FY2025 Earnings Forecast for CGTX Issued By Chardan Capital
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Equities research analysts at Chardan Capital issued their FY2025 EPS estimates for Cognition Therapeutics in a research report issued to clients and investors on Monday, March 24th. Chardan Capital analyst D. Gataulin expects that the company will earn ($0.32) per share for the year. Chardan Capital currently […]
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Equities research analysts at Chardan Capital issued their FY2025 EPS estimates for Cognition Therapeutics in a research report issued to clients and investors on Monday, March 24th. Chardan Capital analyst D. Gataulin expects that the company will earn ($0.32) per share for the year. Chardan Capital currently […]
